Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents

NCT00545467 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

79

Enrollment

OTHER

Sponsor class

Conditions

DSM-IV Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: Aripiprazole

Sponsor

National Taiwan University Hospital

Collaborators

[object Object]
[object Object]